SOURCE: Molecular Insight Pharmaceuticals, Inc.

Molecular Insight Pharmaceuticals, Inc.

March 16, 2010 12:27 ET

Molecular Insight Pharmaceuticals, Inc. to Report Fourth Quarter and Year-End 2009 Financial and Operational Results Today

CAMBRIDGE, MA--(Marketwire - March 16, 2010) - Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced it will report fourth quarter and year-end 2009 financial results today, March 16, 2010.

Following the release of the results this afternoon, the Company will host a conference call at 4:30 p.m., Eastern Time, during which Molecular Insight management will discuss financial and operating highlights.

Conference Call Details
To access the call, dial 888.679.8033 (or 617.213.4846 for international participants) at least five minutes prior to the start of the call. The participant pass code is 97807395. For one week following the call, an audio replay can be accessed by dialing 888.286.8010 (or 617.801.6888 for international callers) and using the pass code 50056981.

An audio webcast of the call will also be available in the "Investor Relations" section of the Company's website, www.molecularinsight.com, for 30 days after the call.

About Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in molecular medicine. The Company is focused on the discovery and development of targeted therapeutic and imaging radiopharmaceuticals for use in oncology. Molecular Insight has five clinical-stage candidates in development. For further information on Molecular Insight Pharmaceuticals, please visit www.molecularinsight.com.

Contact Information